Another mode by which hypoxia and TGF-β cooperate in promoting prostate cancer aggressiveness is the activation of myofibroblasts through chemokine (C-X-C motif) ligand 13 (CXCL13) expression [108]. Here, CXCL13 is linked to prostate carcinoma.